Skip to main content

Roger M Vilardaga, PhD

Assistant Professor in Psychiatry and Behavioral Sciences
Division: 
Behavioral Medicine & Neurosciences
Category: 

Roger Vilardaga, Ph.D. is an Assistant Professor at the Department of Psychiatry and Behavioral Sciences at Duke University. He is also Affiliate Professor a the Department of Human Centered Design and Engineering at the University of Washington. Roger studied psychology at the Universitat de Barcelona and received his doctoral degree in clinical psychology from the University of Nevada, Reno. He has contributed to the study and development of several digital interventions, including Mindful Daily, SmartQuit, Tummy Trials, Eyes Free Yoga, Mindful Powers, and Pain Tracker Self Management. He created and designed Learn to Quit, the first NIH-funded digital therapeutic to deliver smoking cessation treatment for individuals with serious mental illness. This app won the Gold W3 Award in 2016 by the Academy of Interactive and Visual Arts and the Silver Davey International Award in 2016 for best wellness and health app. His work has been featured in FastCompany, The Drum, Seattle K5 News and Psychiatric News. His lab has been funded by the National Institute on Drug Abuse, the University of Washington Innovation Award, Pfizer and Duke University.

He directs the Access to Behavioral Health for All (ABHA) Lab at Duke's Center for Addition Science and Technology. The focus of the ABHA Lab is to ideate, develop, and test digital behavioral health interventions for underserved populations, such as individuals who experience persistent mental health symptoms, addiction, or chronic pain. The lab specializes in: (1) designing digital tools to foster behavioral health and psychological resilience, and (2) the application of rigorous strategies to evaluate them. The lab uses a multi-method approach that includes user-centered design research, small-n experimental designs, clinical trials methodology, and digital phenotyping to better understand the behavior of digital therapeutics users.

Roger has served as ad-hoc reviewer for more than 25 scientific journals and 4 granting institutions (including the US's Center for Scientific Review), and has received grant funding from the National Institute on Drug Abuse, the University of Washington Innovation Award, Pfizer, the National Cancer Institute, and Duke University.

Education and Training

  • Ph.D., University of Nevada, Reno, 2012

Publications

Browne, Julia, Tate F. Halverson, and Roger Vilardaga. “Engagement with a digital therapeutic for smoking cessation designed for persons with psychiatric illness fully mediates smoking outcomes in a pilot randomized controlled trial.” Transl Behav Med, August 4, 2021. https://doi.org/10.1093/tbm/ibab100.

Full Text

Gowarty, Minda A., Meghan R. Longacre, Roger Vilardaga, Nathan J. Kung, Ashley E. Gaughan-Maher, and Mary F. Brunette. “Usability and Acceptability of Two Smartphone Apps for Smoking Cessation Among Young Adults With Serious Mental Illness: Mixed Methods Study.” Jmir Ment Health 8, no. 7 (July 7, 2021): e26873. https://doi.org/10.2196/26873.

Full Text

Schnoll, Robert, Steven L. Bernstein, Annette Kaufman, Robert Gross, Sheryl L. Catz, Patricia A. Cioe, Brian Hitsman, et al. “COVID-19 Challenges Confronted by Smoking Cessation Clinical Trials for People Living with HIV: The Experience of Grantees of the United States National Cancer Institute.” Nicotine Tob Res, February 28, 2021. https://doi.org/10.1093/ntr/ntab035.

Full Text

Vilardaga, Roger, Javier Rizo, Paige E. Palenski, Paolo Mannelli, Jason A. Oliver, and Francis J. McClernon. “Erratum to: Pilot Randomized Controlled Trial of a Novel Smoking Cessation App Designed for Individuals With Co-Occurring Tobacco Dependence and Serious Mental Illness.” Nicotine Tob Res 23, no. 2 (January 22, 2021): 411. https://doi.org/10.1093/ntr/ntaa125.

Full Text

Ashare, Rebecca L., Steven L. Bernstein, Robert Schnoll, Robert Gross, Sheryl L. Catz, Patricia Cioe, Kristina Crothers, et al. “The United States National Cancer Institute's Coordinated Research Effort on Tobacco Use as a Major Cause of Morbidity and Mortality among People with HIV.” Nicotine Tob Res 23, no. 2 (January 22, 2021): 407–10. https://doi.org/10.1093/ntr/ntaa155.

Full Text

Vilardaga, Roger, Tykira Fisher, Paige E. Palenski, Viggy Kumaresan, Paolo Mannelli, Maggie M. Sweitzer, Francis Joseph McClernon, Matthew M. Engelhard, Patricia L. Sabo, and Kathleen A. Garrison. “Review of Popularity and Quality Standards of Opioid-Related Smartphone Apps.” Curr Addict Rep 7, no. 4 (December 2020): 486–96. https://doi.org/10.1007/s40429-020-00344-6.

Full Text

Vilardaga, Roger, Javier Rizo, Paige E. Palenski, Paolo Mannelli, Jason A. Oliver, and Francis J. Mcclernon. “Pilot Randomized Controlled Trial of a Novel Smoking Cessation App Designed for Individuals With Co-Occurring Tobacco Use Disorder and Serious Mental Illness.” Nicotine Tob Res 22, no. 9 (August 24, 2020): 1533–42. https://doi.org/10.1093/ntr/ntz202.

Full Text

Vilardaga, Roger, Pamela Stitzlein Davies, Kevin E. Vowles, and Mark D. Sullivan. “Theoretical Grounds of Pain Tracker Self Manager: An Acceptance and Commitment Therapy Digital Intervention for Patients with Chronic Pain.” J Contextual Behav Sci 15 (January 2020): 172–80. https://doi.org/10.1016/j.jcbs.2020.01.001.

Full Text

Vilardaga, Roger, Javier Rizo, Richard K. Ries, Julie A. Kientz, Douglas M. Ziedonis, Kayla Hernandez, and Francis J. McClernon. “Formative, multimethod case studies of learn to quit, an acceptance and commitment therapy smoking cessation app designed for people with serious mental illness.” Transl Behav Med 9, no. 6 (November 25, 2019): 1076–86. https://doi.org/10.1093/tbm/iby097.

Full Text

Vilardaga, R., and J. P. Vilardaga. “Marching our values forward: Progressing contextual behavioral science in line with its core epistemic assumptions.” Journal of Contextual Behavioral Science 14 (October 1, 2019): 108–10. https://doi.org/10.1016/j.jcbs.2019.10.002.

Full Text

Pages